Macquarie Group’s Passage Bio PASG Stock Holding History

Macquarie Group’s Portfolio PASG Stock Details PASG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-13	Closed	-$1	–	2612
2022 Q1	$1	Hold	13	–	–	﹤0.01%	2616
2021 Q4	$2K	Hold	13	–	–	﹤0.01%	2591
2021 Q3	$3K	Hold	13	–	–	﹤0.01%	2612
2021 Q2	$4K	Hold	13	–	–	﹤0.01%	2535
2021 Q1	$5K	Sell	13 -7	-35%	-$2.99K	﹤0.01%	2447
2020 Q4	$10K	Hold	20	–	–	﹤0.01%	2307
2020 Q3	$5K	Hold	20	–	–	﹤0.01%	2339
2020 Q2	$11K	Buy	+20	New	+$8.99K	﹤0.01%	2278

Other funds holding PASG

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

VVM

Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

HCM

Highline Capital Management New York $53.5M AUM 21.72% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Macquarie Group's PASG Position: Q2 2022 in Review

Macquarie Group sold out of Passage Bio (PASG) in Q2 2022, closing a stake of 13 shares — an estimated $1 sold.

Macquarie Group first reported a position in PASG in Q2 2020 and held it in 8 quarters. The position peaked at $11K in Q2 2020. 85 funds tracked by Wall St. Rank hold PASG as of Q2 2022.

Macquarie Group reported no remaining Passage Bio position as of Q2 2022 after selling out during the quarter.
Macquarie Group sold 13 Passage Bio shares in Q2 2022, an estimated $1.
Macquarie Group first reported a position in Passage Bio in Q2 2020 and held it in 8 quarters.
Macquarie Group's Passage Bio position peaked at $11K in Q2 2020.
85 funds tracked by Wall St. Rank held Passage Bio as of Q2 2022.

Based on Macquarie Group's 13F filing for Q2 2022, filed 15 Aug 2022.